Roman D Büllow1, Jon N Marsh2, S Joshua Swamidass2, Joseph P Gaut2, Peter Boor1,3,4. 1. Institute of Pathology. 2. Washington University School of Medicine in St. Louis, Department of Pathology and Immunology, St. Louis, Missouri, USA. 3. Department of Nephrology and Immunology. 4. Electron Microscopy Facility, RWTH Aachen University Hospital, Aachen, Germany.
Abstract
PURPOSE OF REVIEW: The field of pathology is currently undergoing a significant transformation from traditional glass slides to a digital format dependent on whole slide imaging. Transitioning from glass to digital has opened the field to development and application of image analysis technology, commonly deep learning methods (artificial intelligence [AI]) to assist pathologists with tissue examination. Nephropathology is poised to leverage this technology to improve precision, accuracy, and efficiency in clinical practice. RECENT FINDINGS: Through a multidisciplinary approach, nephropathologists, and computer scientists have made significant recent advances in developing AI technology to identify histological structures within whole slide images (segmentation), quantification of histologic structures, prediction of clinical outcomes, and classifying disease. Virtual staining of tissue and automation of electron microscopy imaging are emerging applications with particular significance for nephropathology. SUMMARY: AI applied to image analysis in nephropathology has potential to transform the field by improving diagnostic accuracy and reproducibility, efficiency, and prognostic power. Reimbursement, demonstration of clinical utility, and seamless workflow integration are essential to widespread adoption.
PURPOSE OF REVIEW: The field of pathology is currently undergoing a significant transformation from traditional glass slides to a digital format dependent on whole slide imaging. Transitioning from glass to digital has opened the field to development and application of image analysis technology, commonly deep learning methods (artificial intelligence [AI]) to assist pathologists with tissue examination. Nephropathology is poised to leverage this technology to improve precision, accuracy, and efficiency in clinical practice. RECENT FINDINGS: Through a multidisciplinary approach, nephropathologists, and computer scientists have made significant recent advances in developing AI technology to identify histological structures within whole slide images (segmentation), quantification of histologic structures, prediction of clinical outcomes, and classifying disease. Virtual staining of tissue and automation of electron microscopy imaging are emerging applications with particular significance for nephropathology. SUMMARY: AI applied to image analysis in nephropathology has potential to transform the field by improving diagnostic accuracy and reproducibility, efficiency, and prognostic power. Reimbursement, demonstration of clinical utility, and seamless workflow integration are essential to widespread adoption.
Authors: Matthew G Hanna; Victor E Reuter; Jennifer Samboy; Christine England; Lorraine Corsale; Samson W Fine; Narasimhan P Agaram; Evangelos Stamelos; Yukako Yagi; Meera Hameed; David S Klimstra; S Joseph Sirintrapun Journal: Arch Pathol Lab Med Date: 2019-06-11 Impact factor: 5.534
Authors: Ambarish M Athavale; Peter D Hart; Mathew Itteera; David Cimbaluk; Tushar Patel; Anas Alabkaa; Jose Arruda; Ashok Singh; Avi Rosenberg; Hemant Kulkarni Journal: JAMA Netw Open Date: 2021-05-03
Authors: Marina Zimmermann; Martin Klaus; Milagros N Wong; Ann-Katrin Thebille; Lukas Gernhold; Christoph Kuppe; Maurice Halder; Jennifer Kranz; Nicola Wanner; Fabian Braun; Sonia Wulf; Thorsten Wiech; Ulf Panzer; Christian F Krebs; Elion Hoxha; Rafael Kramann; Tobias B Huber; Stefan Bonn; Victor G Puelles Journal: JCI Insight Date: 2021-04-08
Authors: Meyke Hermsen; Valery Volk; Jan Hinrich Bräsen; Daan J Geijs; Wilfried Gwinner; Jesper Kers; Jasper Linmans; Nadine S Schaadt; Jessica Schmitz; Eric J Steenbergen; Zaneta Swiderska-Chadaj; Bart Smeets; Luuk B Hilbrands; Friedrich Feuerhake; Jeroen A W M van der Laak Journal: Lab Invest Date: 2021-05-18 Impact factor: 5.502